# Effect of Galantamine on Inflammation and Cognition

> **NCT03384784** · PHASE2 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 63 (actual)

## Conditions studied

- HIV Associated Cognitive Motor Complex

## Interventions

- **DRUG:** Galantamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03384784
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-30
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2024-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03384784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03384784, "Effect of Galantamine on Inflammation and Cognition". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03384784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*